Composition: Bimatoprost 0.03% w/v + Timolol Maleate eq to Timolol 0.5% w/v
Formulation: Eye Drops
Category: Anti-Glaucoma
Packaging: 3ML



Therapy/Class: Anti-Glaucoma
Mechanism of Action:
Timolol Maleate: A non-selective beta-1 and beta-2 adrenergic receptor antagonist lacking significant intrinsic sympathomimetic or membrane-stabilizing activity. It reliably decreases intraocular pressure by fundamentally reducing aqueous humor synthesis in the ciliary processes.
Bimatoprost: A synthetic prostamide analog structurally related to prostaglandin F2α. It potently lowers IOP by stimulating both the trabecular meshwork and uveoscleral outflow pathways, remodeling extracellular matrix to reduce outflow resistance.
Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma
Management of ocular hypertension
Note: This is an indicative Indication, please follow the doctors advise. Do not self medicate.
Instill 1 drop into the inferior conjunctival cul-de-sac of the affected eye(s) as prescribed by the physician. Dosing frequency should be adjusted according to clinical response and severity.
Note: This is an indicative dosage, please follow the doctors advise. Do not self medicate.
1. Zimmerman TJ, et al. Timolol maleate: Efficacy and safety. Arch Ophthalmol. 1979;97(4):656-658.
2. Boger WP 3rd. Timolol: short term escape and long term drift. Ann Ophthalmol. 1979;11(8):1239-1242.
1. Craven ER, et al. Bimatoprost 0.01% and 0.03% in patients with glaucoma or ocular hypertension. Clin Ophthalmol. 2010;4:833-841.
Warning: This information is only for the use of registered medical practitioners only.
Error: Contact form not found.
